ESTRELLA IMMUNOPHARMA INC

ESLA · NASDAQ

Updated at 2026-10-15 07:55:49

$0.31+1.24%
Today's High
$0.32
Today’s Low
$0.30
ESTRELLA IMMUNOPHARMA INC (ESLA) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$0.31
Previous Close
$0.31
Volume
198.94K
Market Cap
$13.82M
P/E Ratio
--
EPS
$-0.25

Previous Day Range

$0.30$0.32

52-Week Range

$0.29$3.15

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
5858 HORTON STREET, EMERYVILLE, CA, UNITED STATES, 94608
Country
US
Listing Date
2021-07-19
Fiscal Year End
December
Shares Outstanding
43.03M
CIK
0001844417

Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company is headquartered in EmeryVille, California.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

$0

2025-09-30

$0

Operating Expenses

2026-06-30

$2.08M

2026-03-31

$2.29M

2025-12-31

$613.19K

2025-09-30

$4.8M

Net Income

2026-06-30

-$2.3M

2026-03-31

-$2.29M

2025-12-31

-$613.17K

2025-09-30

-$4.8M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

Earnings Per Share

2026-06-30

$-0.05

2026-03-31

$-0.05

2025-12-31

$-0.01

2025-09-30

$-0.13

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$2.08M

2026-03-31

-$2.29M

2025-12-31

-$613.19K

2025-09-30

-$4.8M

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-12-31

0%

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.